Reengineering Life Sciences in the Era of Agentic AI
A New Era in Life Science
The life sciences industry is looking toward a future of innovation and better patient outcomes. At the same time, it is navigating unprecedented changes in the marketplace. Frank Defesche, Salesforce SVP and GM of Life Sciences Cloud, explains, “Life sciences is facing unprecedented change fueled by the evolving needs of patients and HCPs (healthcare professionals), emerging industry trends and operating models, increased complexity of treatments, new data sets, and technology advancements spurred by Al across clinical, medical, and commercial functions.”
As the industry continues to expand, so do the regulatory and compliance issues it needs to address. In addition, an increased focus on advanced therapeutic modalities (ATMs) is driving a need for more complex capabilities to support the future of research and development and manufacturing. The evolving societal need to advance health equity is also driving life sciences organizations to invest in initiatives that can help them design better customer engagement programs and have a positive impact on patient outcomes.
